CDMO Capabilities PharmaTech LLC operates as a US-based CDMO offering end-to-end development and manufacturing for both Rx and OTC products, with strict adherence to Current Good Manufacturing Practices, suggesting opportunities to partner for outsourced development, scale-up, and full-product lifecycle support.

US Facility Advantage All products are manufactured in a USA facility, which can appeal to customers prioritizing domestic production, import substitution, tighter regulatory alignment, and quicker supply chain timelines — a compelling selling point for US-based pharma marketers and distributors.

Mid-Market Focus With a team size in the mid hundreds and reported revenue in the mid eight figures, PharmaTech sits between startup-like CDMOs and large-scale manufacturers, indicating potential fit for mid-market pharma companies, regional brands, or distributors seeking reliable partners without the complexity of mega-vendors.

Quality & Compliance Emphasis on quality assurance and FDA-regulatory alignment presents a pathway to win business from companies seeking robust GMP compliance, quality systems, and consistent batch quality for Rx and OTC lines, including private-label or co-development deals.

Growth-Ready Partnership The combination of one-stop development and manufacturing, local US operations, and a capable team suggests opportunities for accelerators, contract manufacturers seeking to expand capacity, or brands planning portfolio expansion, launches, or reformulations with a trusted CDMO partner.